| API NAME | INTERMEDIATE | CAS NO |
|---|---|---|
| APIXABAN | Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate | 27143-07-3 |
| APIXABAN | 3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone | 536760-29-9 |
| APIXABAN | 3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro1H-pyridin-2-1 | 545445-44-1 |
| APIXABAN | 4,5,6,7-Tetrahydro-5-methylthiazolo[5,4-c]pyridine-2-carboxylic acid hcl | 720720-96-7 |
| EDOXABAN | 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride | 1243308-37-3 |
| EDOXABAN | tert-Butyl(1R,2S,5S)-2-amino-5-(dimethylamino)carbamoyl)cyclohexylcarbamate oxalate monohydrate | 1353893-22-7 |
| EDOXABAN | (3aR,4S,6R,6aS)-6-aminotetrahydro-2,2-dimethyl-4H-Cyclopenta-1,3-dioxol-4-ol | 155899-66-4 |
| EDOXABAN | 2-[[(3aR,4S,6R,6aS)-6-aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol | 274693-55-9 |
| EDOXABAN | 4,6-dichloro-2-propylthio-pyrimidine-5-amine | 145783-15-9 |
| EDOXABAN | (1R,2S)-2-(3,4-difluorophenyl)- Cyclopropanamine | 220352-38-5 |
| TICAGRELOR | 2-[[(3aR,4S,6R,6aS)-6-Aminotetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-ethanol - | |
| TICAGRELOR | (2R,3R)-2,3-dihydroxybutanedioate | 376608-65-0 |
| TICAGRELOR | (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride | 1156491-10-9 |
| TICAGRELOR | 4,6-Dichloro-5-nitro-2-propylthiopyrimidine | 145783-14-8 |
| TICAGRELOR | (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate | 376608-71-8 |
| LINAGLIPTIN | (R)-3-Piperidinamine dihydrochloride | 334618-23-4 |
| LINAGLIPTIN | 2-(chloromethyl)-4-methylquinazoline | 109113-72-6 |
| LINAGLIPTIN | (R)-3-(Boc-Amino)piperidine | 309956-78-3 |
| LINAGLIPTIN | 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione | 853029-57-9 |
| SITAGLIPTIN | 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine HCl | 762240-92-6 |
| SITAGLIPTIN | (R)-N-Boc-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid | 486460-00-8 |
| SITAGLIPTIN | 1-ehtyl -3-(3-dimethylamino – propyl) carbodiimide | 25952-53-8 |
| VILDAGLIPTIN | L-Prolinamide | 7531-52-4 |
| VILDAGLIPTIN | 3-Amino-1-Hydroxy Adamantane | 702-82-9 |
| ANIRACETAM | 4-Methoxy Benzoic Acid | 100-09-4 |
| ANIRACETAM | 1-(4-Methoxybenzoyl)-2-pyrrolidinone, Aniracetam | 72432-10-1 |
| SUNITINIB | 5-Formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | 253870-02-9 |
| SUNITINIB | N,N-Diethylethylenediamine | 100-36-7 |
| SUNITINIB | 5-Fluorooxindole | 56341-41-4 |
| RIVAROXABAN | 5-Chlorothiophene-2-carboxylic acid | 24065-33-6 |
| RIVAROXABAN | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 |
| RIVAROXABAN | 5- Chlorothiophene-2-carbonyl chloride | 42518-98-9 |
| RIVAROXABAN | 4-{4-[(5S)-5-(Aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}morpholin-3-one | 446292-10-0 |
| RIVAROXABAN | 2-[(2S)-oxiran-2-ylmethyl]-1H-isoindole-1,3(2H)-dione | 161596-47-0 |
| CAPACITABINE | 2',3'-Di-O-Acetyl-5'-Deoxy-5-Fluorocytidine | 161599-46-8 |
| CAPACITABINE | Fluorocytosine | 2022-85-7 |
| CAPACITABINE | D-Ribose | 50-69-1 |
| CAPACITABINE | 2,3-Di-O-acetyl-5-deoxy-5-fuluro-D-cytidine | 161500-46-8 |
| CAPACITABINE | 5'-Deoxy-5-fluorocytidine | 66335-38-4 |
| BREXIPIPRAZOLE | 7-(4-Chlorobutoxy)-2(1H)-quinolinone | 913613-82-8 |
| BREXIPIPRAZOLE | 1-Benzo[b]thiophene-4-yl-piperazine hydrochloride | 913614-18-3 |
| BREXIPIPRAZOLE | 7-Hydroxyquinolinone | 70500-72-0 |
| BREXIPIPRAZOLE | 4-chloro- Benzo[b]thiophene. | 66490-33-3 |
| BREXIPIPRAZOLE | 4-BROMO-BENZO[B]THIOPHENE | 5118-13-8 |
| VORICONAZOLE | 4-Chloro-6-Ethyl-5 Fluoro Pyrimidine | 137234-74-3 |
| VORICONAZOLE | 2,4-Difluoro-alpha-(1H-1,2,4-triazolyl)acetophenone | 86404-63-9 |
| VORICONAZOLE | 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine | 188416-28-6 |
| TOFACITINIB | 4-Chloropyrrolo[2,3-d]pyrimidine | 3680-69-1 |
| TOFACITINIB | 2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine | 90213-66-4 |
| TOFACITINIB | N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 477600-74-1 |
| PREGABALIN | (S)-3-cyano-5-methylhexanoic acid ethyl ester | 181289-39-4 |
| PREGABALIN | R-(+)-1-phenyl-ethylamine | 3886-69-9 |
| PREGABALIN | 3-Carbamoyl methyl-5-methyl hexanoic acid | 181289-15-6 |
| PREGABALIN | (R)-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid | 181289-33-8 |
| ERTAPENEM | beta-Methyl vinyl phosphate CAS NO. 90776-59- | 90776-59-3 |
| SODIUM | 2-[[(3-Carboxyphenyl)amino]carbonyl]-4-mercapto-1-pyrrolidinecarboxylic acid (2S-cis)-1-[(4-nitrophenyl)methyl] ester | 202467-69-4 |
| OLMESARTAN | Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-Carboxylate | 144689-93-0 |
| OLMESARTAN | 4-Cloromethyl-5-methyl-1,3-dioxol-2-one （DMDO-CL） | 80841-78-7 |
| OLMESARTAN | 4'-Methyl-2-cyanobiphenyl | 114772-53-1 |
| SILODOSIN | 2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethyl methanesulfonate | 160969-03-9 |
| SILODOSIN | 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate | 239463-85-5 |
| SILODOSIN | 1-Acetyl-5-(2-aminopropyl)-2,3-dihydro-1H-indole-7-carbonitrile | 175837-01-1 |
| PALBOCICLIB | 6-Bromo-8-cyclopentyl-2-chloro-5-Methyl-8H-pyrido[2,3-d]pyriMidin-7-one | 1016036-76-2 |
| PALBOCICLIB | tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate | 571188-59-5 |
| AXITINIB | Xantphos or 4,5-Bis(diphenylphosphino)-9,9-dimethyl xanthene | 161265-03-8 |
| AXITINIB | Tris(o-Tolyl)phosphine or P(o-Tol)3 | 6163-58-2 |
| AXITINIB | 3,4-Dihydro-2H-pyran | 110-87-2 |
| AXITINIB | Di-tert-butyl dicarbonate (BOC-anhydride) | 24424-99-5 |
| NINTEDANIB | N-(4-Aminophenyl)-N,4-dimethyl-1-piperazineacetamide | 262368-30-9 |
| NINTEDANIB | (3E)-2,3-Dihydro-3-(methoxyphenylmethylene)-2-oxo-1H-indole-6-carboxylic acid methyl este | 1168150-46-6 |
| NINTEDANIB | Methyl (3Z)-1-acetyl-3-[ethoxy(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate | 1027407-75-5 |
| NINTEDANIB | 4-(Methoxycarbonyl)-2-nitrobenzeneacetic acid methyl ester | 334952-07-7 |
| AFATINIB | 4-Chloro-7-fluoro-6-nitroquinazoline | 162012-70-6 |
| AFATINIB | 3-Chloro-4-fluoroaniline | 367-21-5 |
| AFATINIB | (S)-3-Hydroxytetrahydrofuran | 86087-23-2 |
| AFATINIB | N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine | 162012-67-1 |
| AFATINIB | N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[(3S)-tetrahydrofuran -3-yloxy] | 1027407-75-5 |
| CLOPIDOGREL BISULFATE | Thiophene-2-ethanol | 5402-55-1 |
| CLOPIDOGREL BISULFATE | Thiophene-2-ethylamine | 30433-91-1 |
| CLOPIDOGREL BISULFATE | L-(-)-Camphoresulfonic acid | 35963-20-3 |
| CLOPIDOGREL BISULFATE | DL-2-(2-Chlorophenyl)glycine | 141196-64-7 |
| MONTELUKAST | 2-[1-(Mercaptomethyl)cyclopropyl]acetic acid | 162515-68-6 |
| SODIUM | 2-(2-(3s)-(3-(2-(7-chloro-2-qionolinyl)-ethenyl-phenyl)-3-hydroxy-propyl) phenyl)-2-propanol | 142569-70-8 |
| TELMISARTAN | 4'-Bromomethyl-(1,1'-biphenyl)-2-carboxylic acid methyl ester | 114772-38-2 |
| TELMISARTAN | Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate | 152628-01-8 |
| TELMISARTAN | 2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole | 152628-02-9 |
| TELMISARTAN | Telmisartan methyl ester | 528560-93-2 |
| MOXIFLOXACIN | (S,S)-2,8-Diazabicyclo[4,3,0]nonane | 151213-42-2 |
| MOXIFLOXACIN | 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid | 112811-72-0 |
| MOXIFLOXACIN | 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester | 112811-71-9 |
| EZETIMIB | (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-[4-(phenylmethoxy)phenyl]-2-azetidinone | 163222-32-0 |
| EZETIMIB | (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone | 189028-93-1 |
| EZETIMIB | (3R,4S)-4-[4-(Benzyloxy)phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]azetidin-2-one | 190595-65-4 |
| EZETIMIB | Methyl (3R,4S)-1-(4-fluorophenyl)-2-oxo-4-[4-(phenylmethoxy)phenyl]-3-azetidinepropanoate | 204589-80-0 |
| EZETIMIB | (R)-2-Methyl-CBS-oxazaborolidine | 112022-83-0 |
| EZETIMIB | 4-(4-Hydroxybenzylidene)Fluoroaniline | 3383-63-6 |
| TERBINAFINE | 1-Chloro-6,6-dimethyl-2-heptene-4-yne | 83554-69-2 |
| TERBINAFINE | N-Methyl-1-naphthalenemethylamine hydrochloride | 65473-13-4 |
| TERBINAFINE | 6,6-Dimethyl-1-hepten-4-yn-3-ol | 78629-20-6 |
| TERBINAFINE | 2E) N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine | 91161-71-6 |
| TERBINAFINE | 1-Methyl-aminomethyl naphthalene | 14489-75-9 |
| LEVETIRACETAM | L-2-Aminobutanamide hydrochloride | 7682-20-4 |
| LEVETIRACETAM | L(+)-2-Aminobutyric acid | 1492-24-6 |
| BOSENTAN | 4-tert-Butylbenzenesulfonamide | 6292-59-7 |
| BOSENTAN | 2-Amidinopyrimidine hydrochloride | 138588-40-6 |
| BOSENTAN | 4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine | 150728-13-5 |
| BOSENTAN | 5-(2-Methoxyphenoxy)-[2,2'-bipyrimidine]-4,6(1H,5H)-dione | 150728-12-4 |
| CITICOLIN | Cytidine 5'-Monophosphate | 63-37-6 |
| CITICOLIN | N,N′-Dicyclohexylcarbodiimide | 538-75-0 |
| CITICOLIN | cytosine | 71-30-7 |
| DULOXETINE | 1-Fluoronaphthalene | 321-38-0 |
| DULOXETINE | S-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine | 132335-44-5 |
| DULOXETINE | N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine | 13636-02-7 |
| DULOXETINE | S-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate | 132335-47-8 |
| EMPAGIFLOZIN | (S)-(+)-3-Hydroxytetrahydrofuran | 86087-23-2 |
| EMPAGIFLOZIN | (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan | 915095-94-2 |
| EMPAGIFLOZIN | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 |
| EMPAGIFLOZIN | (3S)-Tetrahydro-3-Furanyl 4-Methylbenzenesulfonate | 112052-11-6 |
| EMPAGIFLOZIN | (3R)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran | 915095-90-8 |
| CANAGIFLOZIN | 5-Bromo-2-methylbenzoic acid | 79669-49-1 |
| CANAGIFLOZIN | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 |
| CANAGIFLOZIN | 2-(4-Fluorophenyl)thiophene | 58861-48-6 |
| CANAGIFLOZIN | 2,3,4,6-Tetra-O-benzyl-D-glucono-1,5-lactone | 13096-62-3 |
| CANAGIFLOZIN | 5-Iodo-2-methylbenzoic acid | 54811-38-0 |
| CANAGIFLOZIN | 4-(5-BROMO-2-CHLOROBENZYL)PHENOL | 864070-18-8 |
| DAPAGIFLOZIN | (5-BroMo-2-chlorophenyl)(4-ethoxyphenyl)Methanone | 461432-22-4 |
| DAPAGIFLOZIN | 5-Bromo-2-chloro-4’-ethoxydiphenylmethane | 461432-23-5 |
| DAPAGIFLOZIN | 2-Chloro-5-nitrobenzoic Acid | 2516-96-3 |
| DAPAGIFLOZIN | 5-Bromo-2-Chloro Benzoic acid | 21739-92-4 |
| DAPAGIFLOZIN | D-Gluconic acid, 2,3,4,6-tetrakis-O-(triMethylsilyl)-, d-lactone | 32384-65-9 |
| OSELTAMAVIR | (1S,5R,6S)-Ethyl 5-(pentan-3-yl-oxy)-7-oxa-bicyclo[4.1.0]hept-3-ene-3-carboxylate | 204254-96-6 |
| IMATINIB | N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-Pyrimidineamine | 152460-10-1 |
| MESYLATE | 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride | 106261-49-8 |
| VALSARTAN | N-(2'-Cyanobiphenyl-4-ylmethyl)-L-valine Methyl Ester Hydrochloride | 482577-59-3 |
| VALSARTAN | 4-Bromomethyl-2-cyanobiphenyl | 114772-54-2 |
| VALSARTAN | L-Valine methyl ester hydrochloride | 6306-52-1 |
| VALSARTAN | 5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenylmethyl-1H-tetrazole | 124750-51-2 |
| ROSUVASTATIN | (4R-cis)-6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-aceticAcid tert-Butyl Ester(D5) | 154026-94-5 |
| ROSUVASTATIN | tert-Butyl (4R-cis)-6-[(acetyloxy)methyl]-2,2-dimethyl-1,3-dioxane-4-acetate（D5） | 154026-95-6 |
| ROSUVASTATIN | 4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-n-methylsulfonyl)amino]pyrimidine-5-yl-methanol（Z7) | 147118-36-3 |
| ROSUVASTATIN | Tert-Butyl 6-[(1E)-2-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]ethenyl]-2,2 | |
| ATORVASTATIN | -dimethyl-1,3-dioxane-4-acetate | 289042-12-2 |
| ATORVASTATIN | tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate | 125971-95-1 |
| ATORVASTATIN | (4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate | 125995-13-3 |
| ATORVASTATIN | Benzyl (4-hydroxybutyl)carbamate | 17996-13-3 |
| ATORVASTATIN | 3-[(Benzyloxycarbonyl)amino]propionaldehyde | 65564-05-8 |
| ATORVASTATIN | [R-(R*, R*)]-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylaminocarbonyl)-1H-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid calcium salt | 134523-03-8 |
| ATORVASTATIN | Fluorobenzene | 462-06-6 |
| BRIVARACETAM | 5-hydroxy-4-propylfuran-2(5H)-one | 78920-10-2 |
| BRIVARACETAM | (4S)-Brivaracetam | 357336-19-7 |
| BRIVARACETAM | (R)-4-PROPYLPYRROLIDIN-2-ONE | 930123-37-8 |
| BRIVARACETAM | 4-propyl-2-Pyrrolidinone | 89895-19-2 |
| BRIVARACETAM | ETHYL 3-(NITROMETHYL)HEXANOATE | 128013-61-6 |
| BRIVARACETAM | Ethyl (E)-hex-2-enoate | 27829-72-7 |
| BRIVARACETAM | (R)-Dihydro-4-propyl-2(3H)-furanone | 63095-51-2 |
| BENDAMUSTIN HCL | 4-{5-[Bis-(2-hydroxy-ethyl)-amino]-1-methyl-1H-benzoimidazol-2-yl}-butyric acid ethyl ester | 3543-74-6 |
| BENDAMUSTIN HCL | 4-(5-Amino-1-methyl-1H-benzoimidazol-2-yl)-butyric acid ethyl ester | 3543-73-5 |
| RUCAPARIB | 4-Fluoro-1,3-dihydro-2H-indol-2-one | 138343-94-9 |
| RUCAPARIB | 6-Fluoro-1,3-dihydro-2H-Indol-2-one | 56341-39-0 |
| LEFLUNOMIDE | 5-Methylisoxazole-4-carboxylic Acid | 42831-50-5 |
| LEFLUNOMIDE | 2-Bromo-5-Fluoro Benzaldehyde | 9456984-3 |
| TAVABOROLE | Bis (Pinacolato)di borane | 73183-34-3 |
| TAVABOROLE | 1,1’Bis (diphenylphosphino)Ferrocene (dppf) CAS NO. | 12150-46-8 |
| IGURATIMOD | N-[4-[(Formylamino)acetyl]-5-hydroxy-2-phenoxyphenyl]methanesulfonamide | 149457-03-4 |
| IGURATIMOD | 4-Chloro-3-nitroanisole | 10298-80-3 |
| IGURATIMOD | N-(4-(2-Aminoacetyl)-5-methoxy-2-phenoxyphenyl)methanesulfonamide hydrochloride | 149436-41-9 |
| IGURATIMOD | N-(5-methoxy-2-phenoxyphenyl)methanesulfonamid | 88381-56-7 |
| PAZOPANIB | 2,3-Dimethyl-2H-indazol-6-ylamine | 106649-95-0 |
| PAZOPANIB | 2,4-Dichloropyrimidine | 88046-01-9 or 3934-20-1 |
| NILOTINIB | 2,3-DIMETHYL-2H-INDAZOL-6-AMINE | 444731-72-0 |
| NILOTINIB | 4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YL AMINO)-BENZOIC ACID | 641569-94-0 |
| NILOTINIB | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline | 641571-11-1 |
| ELTROMBOPAG | 2-Bromo-6-nitrophenol | 13073-25-1 |
| ELTROMBOPAG | 1-Bromo-2-methoxy-3-nitrobenzene | 98775-19-0 |
| ELTROMBOPAG | 3,4-Dimethylphenylhydrazine hydrochloride | 60481-51-8 |
| MIRABEGRON | 2-(4-Nitrophenyl)ethylamine hydrochloride | 29968-78-3 |
| MIRABEGRON | 2-Amino-4-thiazoleacetic acid hydrochloride | 66659-20-9 |
| MIRABEGRON | (alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride | 521284-22-0 |
| MIRABEGRON | 5-Methylisoxazole-4-(4-trifluoromethyl)carboxanilide | 75706-12-6 |
| BILASTINE | 2-(4-Bromophenyl)-2-methylpropionic acid | 32454-35-6 |
| BILASTINE | 2-Methyl-2-phenylpropionic acid | 826-55-1 |
| REMOGLIFLOZIN | 4-(4-isopropoxybenzyl)-5-methyl-1H-pyrazol-3(2H)-one | 329044-14-6 |
| REMOGLIFLOZIN | 4-(4-isopropoxybenzyl)-1-isopropyl-5-methyl-1H-pyrazol-3(2H)-one | 1028026-83-6 |
| REMOGLIFLOZIN | 2R,3R,4S,5R,6R)-2-(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyl triacetate | 572-09-8 |
| BRINZOLAMIDE | Hydroxylamine-O-sulfonic acid | 2950-43-8 |
| BRINZOLAMIDE | (S)-3,4-Dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide | 154127-42-1 |
| BRINZOLAMIDE | 6-Chloro-2,3-dihydro-4H-thieno[3,2-e][1,2]thiazin-4-one 1,1-dioxide | 174139-69-6 |
| RALTEGRAVIR | 2-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide | 518048-03-8 |
| RALTEGRAVIR | methyl 5-hydroxy-4-oxo-2-[2-(phenylmethoxycarbonylamino)propan-2-yl]-1H-pyrimidine-6-carboxylate | 519032-08-7 |
| RALTEGRAVIR | Potassium 5-Methyl-1,3,4-oxadiazole-2-carboxylate. | 888504-28-7 |
| OZENOXACIN | [6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]boronic acid | 446299-81-6 |
| OZENOXACIN | 5-bromo-N,3-dimethylpyridin-2-amine | 245765-66-6 |
| OZENOXACIN | ethyl 7-chloro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate | 103877-51-6 |
| LIFITEGRAST | 2-(Tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid | 851784-82-2 |
| LIFITEGRAST | Methyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate hydrochloride | 851785-21-2 |
| LIFITEGRAST | benzofuran-6-carboxylic acid | 77095-51-3 |
| BETRIXABAN | 2-Amino-5-chloropyridine | 1072-98-6 |
| BETRIXABAN | (2-amino-N-(5-chloropyridin-2-yl)-5-methoxybenzamide) | 1183836-56-7 |
| BETRIXABAN | 4-Cyanobenzoic acid | 619-65-8 |
| BETRIXABAN | 4-[(Dimethylamino)iminomethyl]benzoic acid monohydrochloride | 210963-78-3 |
| BETRIXABAN | 5-Methoxy-2-nitrobenzoic acid | 1882-69-5 |
| PLERIXAFOR | 1,4,8,11-Tetraazacyclotetradecane | 295-37-4 |
| PLERIXAFOR | 1,4-Bis(bromomethyl) benzene | 623-24-5 |
| TEMOZOLOMIDE | 4-Nitrophenyl chloroformate | 7693-46-1 |
| TEMOZOLOMIDE | 5-amino-1-(N-methylcarbamoyl)imidazole-4-carboxamide | 188612-53-5 |
| OMADACYCLINE TOSYLATE | (4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-N,9-bis((1,3-dioxoisoindolin-2-yl)methyl)-3,10,12,12a-tetrahydroxy- | |
| OMADACYCLINE TOSYLATE | ||
| OMADACYCLINE TOSYLATE | 1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide | 835877-67-3 |
| OMADACYCLINE TOSYLATE | (4S,4aS,5aR,12aS)-N,9-bis(aminomethyl)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6 | |
| OMADACYCLINE TOSYLATE | ,11,12a-octahydrotetracene-2-carboxamide | 835877-68-4 |
| OMADACYCLINE TOSYLATE | (4S,4aS,5aR,12aS)-9-(aminomethyl)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11, | |
| OMADACYCLINE TOSYLATE | 12a-octahydrotetracene-2-carboxamide | 488820-34-4 |
| TEBIPENEM | beta-Methyl vinyl phosphate | 90776-59-3 |
| TEBIPENEM | 3-Azetidinethiol, 1-(4,5-dihydro-2-thiazolyl)-, monohydrochloride | 179337-57-6 |
| TEBIPENEM | Chloromethyl Pivalate | 18997-19-8 |
| LAPATINIB | 4-Chloro-7-methoxy-quinoline-6-carboxylic acid amide | 417721-36-9 |
| LAPATINIB | 4-Amino-3-chlorophenol hydrochloride | 52671-64-4 |
| LAPATINIB | 4-(3-fluorobenzyloxy)-3-chlorobenzenamine | 202197-26-0 |
| LAPATINIB | 4-chloro-6-iodoquinazoline | 98556-31-1 |
| BENAZEPRIL | L-Homophenylalanine ethyl ester hydrochloride | 90891-21-7 |
| BENAZEPRIL | 3-Bromo-2,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one | 86499-96-9 |
| BENAZEPRIL | S-ATBA | 109010-60-8 |
| BENAZEPRIL | Ethyl (R)-2-hydroxy-4-phenylbutyrate | 90315-82-5 |
| FAROPENEM | Tetrahydro-2-furancarboxylic acid | 16874-33-2 |
| FAROPENEM | (3R,4R)-4-Acetoxy-3-[(R)-(tert-butyldimethylsilyloxy)ethyl]-2-azetidinone | 76855-69-1 |
| FAROPENEM | S-(-)-a-Methylbenyl amine | 2627-86-3 |
| FAROPENEM | Sodium 2-ethylhexanoate | 19766-89-3 |
| LENVATINIB | 4-Chloro-7-methoxyquinoline-6-carboxamide | 417721-36-9 |
| LENVATINIB | N-(2-Chloro-4-hydroxyphenyl)-N'-cyclopropyl-urea | 796848-79-8 |
| TEDIZOLID | (R)-3-(4-Bromo-3-fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one | 444335-16-4 |
| TEDIZOLID | 2-(2-Methyl-2H-tetrazol-5-yl)pyridine-5-boronic acid pinacol ester | 1056039-83-8 |
| TEDIZOLID | (5R)-3-(4-Bromo-3-fluorophenyl)-5-hydroxymethyloxazolidin-2-one | 444335-16-4 |
| GLICLAZIDE | 3-Amino-3-azabicyclo[3.3.0]octane hydrochloride | 58108-05-7 |
| GLICLAZIDE | 3-Amino-3-azabicyclo[3.3.0]octane | 54528-00-6 |
| GLICLAZIDE | 3-Azabicyclo[3.3.0]octane hydrochloride | 112626-50-3 |
Our sourcing function is designed to help our clients identify and work with reputable and reliable overseas companies that manufacture the products they require. Whether the product is readily available or needs custom synthesis, we use our in-depth understanding of the production processes and knowledge of the infrastructural and chemical capabilities of different manufacturers to help identify the right candidates for our principles.
Our export function focuses on promoting Indian-made pharmaceutical finished products and raw material to customers in countries across the globe.
